Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.30 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1136850 | 1.00 | ALPL (0.32) | ALPLP4HBMAOBUSP30ABCB1 | |
| SCHEMBL3000938 | 0.82 | MAOB (0.38) | ALPLP4HBMAOBALKCYP17A1 | |
| SCHEMBL3000928 | 0.82 | MAOB (0.38) | ALPLP4HBMAOBALKCYP17A1 | |
| SCHEMBL1136797 | 0.77 | ABCB1 (0.46) | USP30ABCB1ALK | |
| SCHEMBL1136795 | 0.77 | ABCB1 (0.46) | USP30ABCB1ALK | |
| SCHEMBL18320617 | 0.68 | ALPL (0.45) | ALPLP4HB | |
| SCHEMBL1136707 | 0.67 | MAPT (0.44) | MAOBALK | |
| SCHEMBL1136706 | 0.67 | MAPT (0.44) | MAOBALK | |
| SCHEMBL1136702 | 0.64 | CYP17A1 (0.41) | CYP17A1CYP21A2CYP11B1 | |
| SCHEMBL1136704 | 0.64 | CYP17A1 (0.41) | CYP17A1CYP21A2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1919905-B1 | 3,5-DISUBSTITUTED PYRID-2-ONES USEFUL AS INHIBITORS OF TEC FAMILY OF NON-RECPTOR TYROSINE KINASES | VERTEX PHARMA (US) | 2011-02-23 | — | — | EP | disclosed |